Skip to search boxSkip to navigationSkip to main content

The hemodynamic response to chronic hyperinsulinemia in conscious dogs

  • Michael W. Brands(corresponding author)
    ,
  • H. Leland Mizelle
    ,
  • Carlo A. Gaillard
    ,
  • Drew A. Hildebrandt
    ,
  • John E. Hall
*Corresponding author for this work
  • University of Mississippi
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

This study describes the hemodynamic effects of chronic hyperinsulinemia in seven normal dogs. Insulin infused at 1 mU/kg/min together with glu­cose at 14 mg/kg/min for 7 days increased fasting plasma insulin concentration approximately six­fold. Plasma glucose concentration was unchanged on day 1 but was below control on day 6. Mean ar­terial pressure decreased from 81 ± 4 mm Hg to 70 ± 3 mm Hg, while cardiac output increased to 30 ± 8% above control by day 7. Total peripheral resistance decreased to 69 ± 5% of control. Urinary sodium ex­cretion was significantly decreased and was accom­ panied by a 22% increase in extracellular fluid vol­ume with no change in blood volume. All parame­ters returned to control levels during the recovery period. These data suggest that, in addition to pro­moting renal sodium retention, insulin may lower blood pressure and increase cardiac output through a peripheral vasodilatory effect.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 164-168 (5 pages)

Journal (Volume, Issue Number)

American journal of hypertension (Volume 4, Issue 2)

Publication milestones

  • Published - 11/1991

Publication status

Published - 11/1991

ISSN

0895-7061

Publication IDs

  • Scopus: 0025963669
  • PubMed: 2021447

Publication metrics

Metrics

Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
91
Captures
6

Funding Details

This work was supported by National Institutes of Health grants HL39399, HL11678, and HL23502, and by the Netherlands Organization for Scientific Research. Drs. Brands and Hildebrandt are recipients of National Institutes of Health Individual National Research Service Awards HL08171 and HL07931.
FundersFunding numbers
NIH
HL11678, HL23502
NHLBI
R01HL039399
NWO
-